AsMedic
Asthma Anti-inflammatory Medication Control
Startup A Health Tech & Life Sciences Est. 2005
Total Raised
$500K
A
Last Round
$500K
1 rounds
Investors
1
1 public
Team
1
1-10 employees
Confidence
88/100
Patents
1
About
AsMedic develops solutions to address the dynamic relationship between airway obstruction level and the correct drug dosage to treat asthma. AsMedics platform technology and concept are designed to ensure efficient and personalized drug therapy by delivering the optimal preplanned dosage into the lungs. Because the platform facilitates varied drug dosages, the patient can control the lungs deposition and bioavailability, improving therapy control and significantly decreasing the side effects of inhaled steroids.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Core Technology
Sensing
Target Customer
Healthcare & Life SciencesHealthcarePatients
Business Model
B2C
Tags
non-invasiveinhalationasthmadrug-deliverymedical-devicesmedicationpersonalizationrespiratorychronic-patientshome-care
Funding & Events
Nov 2014
A Round $500K
Pharmaceutical company
Details
Product Stage
Alpha
Employees
1-10
Exact Count
5
District
North District
Founded
2005
Registrar
513762088
Crunchbase
asmedic
Locations
HaTichon St 14, Haifa, Israel
Links
Admin
Last Update
Apr 24, 2025
Verified by
Yotam Maman
Claimed
Yes
Missing
news, markets, external profiles, not claimed
Team (1)
Arie Huber
CEO